Staidson (Beijing) BioPharmaceuticals Co., Ltd. (SHE:300204)
16.15
-0.34 (-2.06%)
Nov 17, 2026, 3:04 PM CST
SHE:300204 Market Cap
SHE:300204 has a market cap or net worth of 8.74 billion as of November 16, 2026. It is the 8,332nd most valuable company in the world and the 1,684th biggest in China. Its market cap has decreased by 53.44% in one year.
Market Cap
8.74B
Enterprise Value
7.67B
Revenue
186.88M
Global Rank
Country Rank
#1,684 China
PE Ratio
n/a
ChartMarket Cap Chart
Since April 15, 2011, SHE:300204's market cap has increased from 3.33B to 8.74B, an increase of 162.76%. That is a compound annual growth rate of 6.39%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 17, 2026 | 8.74B | -33.02% |
| Dec 31, 2025 | 13.05B | 268.69% |
| Dec 31, 2024 | 3.54B | -27.07% |
| Dec 29, 2023 | 4.85B | -24.38% |
| Dec 30, 2022 | 6.42B | -22.12% |
| Dec 31, 2021 | 8.24B | 94.35% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Tibet Cheezheng Tibetan Medicine | 10.50B |
| Shanghai Medicilon | 10.16B |
| Novoprotein Scientific | 9.40B |
| Chongqing Genrix Biopharmaceutical | 9.28B |
| Shanghai OPM Biosciences | 9.23B |
| Mabwell (Shanghai) Bioscience | 8.80B |
| Jiangsu Sinopep-Allsino Biopharmaceutical | 8.74B |
| Hualan Biological Vaccine | 8.73B |